Zanovello, Luigi
Löffler, Richard J. G.
Caraglio, Michele
Franosch, Thomas
Hanczyc, Martin M.
Faccioli, Pietro
Funding for this research was provided by:
Austrian Science Fund (P 35872-N, P 35580-N)
Article History
Received: 30 November 2022
Accepted: 24 March 2023
First Online: 6 April 2023
Competing interests
: PF is co-founder and share holder of Sibylla Biotech SPA, a company involved in early stage drug discovery. The remaining authors do not possess any competing interests.